Rituximab in relapsing-remitting multiple sclerosis: a 72-week, open-label, phase I trial (Q45119459)
Jump to navigation
Jump to search
scientific article published in March 2008
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Rituximab in relapsing-remitting multiple sclerosis: a 72-week, open-label, phase I trial |
scientific article published in March 2008 |
Statements
1 reference
Rituximab in relapsing-remitting multiple sclerosis: a 72-week, open-label, phase I trial (English)
1 reference
Emmanuelle Waubant
1 reference
Amit Bar-Or
1 reference
Peter A J Calabresi
1 reference
Douglas Arnold
1 reference
Clyde Markowitz
1 reference
Stuart Shafer
1 reference
Lloyd H Kasper
1 reference
Suzanne Gazda
1 reference
Robert J Fox
1 reference
Michael Panzara
1 reference
Neena Sarkar
1 reference
Sunil Agarwal
1 reference
Craig H Smith
1 reference
1 March 2008
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference